adr_usa_0504|MITO|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0504|MITO|1|Stealth BioTherapeutics Corp Total Current Assets (Quarterly) (USD)|Stealth BioTherapeutics Corp Cash and Short Term Investments (Quarterly) (USD)|Stealth BioTherapeutics Corp Inventories (Quarterly) (USD)|Stealth BioTherapeutics Corp Net PP&E (Quarterly) (USD)|Stealth BioTherapeutics Corp Goodwill and Intangibles (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Current Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Long Term Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Deposits (Quarterly) (USD)|Stealth BioTherapeutics Corp Book Value (Quarterly) (USD)|Stealth BioTherapeutics Corp Retained Earnings (Quarterly) (USD)|Stealth BioTherapeutics Corp Treasury Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp EV to Revenues|Stealth BioTherapeutics Corp EV to Earnings|Stealth BioTherapeutics Corp EV to Free Cash Flow|Stealth BioTherapeutics Corp EV to Assets (Quarterly)|Stealth BioTherapeutics Corp PS Ratio|Stealth BioTherapeutics Corp PE Ratio|Stealth BioTherapeutics Corp Price to Book Value|Stealth BioTherapeutics Corp PEG Ratio|Stealth BioTherapeutics Corp Debt to Equity Ratio|Stealth BioTherapeutics Corp Dividend Yield|Stealth BioTherapeutics Corp Shareholder Yield (TTM)|Stealth BioTherapeutics Corp Percent of Shares Outstanding Short|Stealth BioTherapeutics Corp Total Receivables (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Payables (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Capital Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp Return on Invested Capital|Stealth BioTherapeutics Corp Quality Ratio Score|Stealth BioTherapeutics Corp Momentum Score|Stealth BioTherapeutics Corp Beta (1Y)|Stealth BioTherapeutics Corp Sustainable Growth Rate (TTM)|Stealth BioTherapeutics Corp Institutional Investor Ownership Percentage|Stealth BioTherapeutics Corp Average Diluted Shares Outstanding (Quarterly)|Stealth BioTherapeutics Corp Total Employees (Annual)|Stealth BioTherapeutics Corp EPS Diluted (Quarterly) (USD)|Stealth BioTherapeutics Corp Shares Outstanding|Stealth BioTherapeutics Corp Repurchase of Capital Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp Ordinary Shares Number (Quarterly)|Stealth BioTherapeutics Corp Payout Ratio|Stealth BioTherapeutics Corp Quick Ratio (Quarterly)|Stealth BioTherapeutics Corp Normalized Diluted EPS (Quarterly) (USD)|Stealth BioTherapeutics Corp Stock Buybacks (Quarterly) (USD)|Stealth BioTherapeutics Corp Effective Tax Rate (TTM)|Stealth BioTherapeutics Corp Return on Equity|Stealth BioTherapeutics Corp Net Income (TTM) (USD)|Stealth BioTherapeutics Corp Revenue (TTM) (USD)|Stealth BioTherapeutics Corp Dividend Per Share (Quarterly) (USD)|Stealth BioTherapeutics Corp Revenue (Quarterly) (USD)|Stealth BioTherapeutics Corp Gross Profit (Quarterly) (USD)|Stealth BioTherapeutics Corp SG&A Expense (Quarterly) (USD)|Stealth BioTherapeutics Corp Pre-Tax Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Net Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Net Interest Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Price (USD)|Stealth BioTherapeutics Corp Total Return Price (USD)|Stealth BioTherapeutics Corp Enterprise Value (USD)|Stealth BioTherapeutics Corp 30-Day Average Daily Volume|Stealth BioTherapeutics Corp 1 Year Price Returns (Daily)||
adr_usa_0504|MITO|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0504|MITO|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
adr_usa_0504|MITO|5|114|114|0|114|0|114|114|114|0|114|121.666666667|0|0|0|0|91|0|0|1.44191919192|0|0|1.44600938967|0|15.2051282051|0|114|121.666666667|0|0|30.5|30.5714285714|0|39.2142857143|91.2|365|91.2|30.3333333333|0|114|0|0|91.2|0|0|0|91.2857142857|0|0|0|0|91.2|91.2|91.2|91.2|1.44600938967|1.44600938967|1.44600938967|1.44584382872|1.42528735632||
adr_usa_0504|MITO|6|8|8|0|8|0|8|8|8|0|8|6|0|0|0|0|2|0|0|396|0|0|426|0|39|0|8|6|0|0|6|7|0|14|10|1|10|18|0|8|0|0|10|0|0|0|7|0|0|0|0|10|10|10|10|426|426|426|397|174||
adr_usa_0504|MITO|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
adr_usa_0504|MITO|201712|5.92|4.1188||0.7959||298.441|24.5946|273.8464||-291.2861|-329.5568|||||||||||||||7.4546|0.0205|||||||20.384||-1.0827|||396.221|||-1.0847|||||||||3.5627|-22.07|-22.07|-1.5405|||||||
adr_usa_0504|MITO|201803||||||||||||||||||||||||||||||||||20.384||-0.9979||||||-0.9953|||||||||3.496|-20.341|-20.341|-3.356|||||||
adr_usa_0504|MITO|201806||||||||||||||||||||||||||||||||||20.384||-1.3274||||||-1.0418|||||||||4.29|-27.057|-27.057|-4.846|||||||
adr_usa_0504|MITO|201809|5.0301|4.0783||0.5725||44.5209|31.6672|12.8538||-32.8912|-399.6797|||||||||||||||8.8263|0.0881|||||||20.384||-1.1148|||396.221|||-1.3273||||-92.193|||||4.755|-22.725|-22.725|-6.079|||||||
adr_usa_0504|MITO|201812|13.293|10.855||0.499||402.229|40.611|361.618||-386.706|-426.269|||||||||||0||0.149||11.023|0.021|||||||33.0184|57|-0.8053|34.4416||396.221|||-0.8438||||-96.712|||||9.676|-26.589|-26.589|-6.881|11.92|11.92|521.7279||||
adr_usa_0504|MITO|201903|72.094|70.497||0.433||38.935|26.48|12.455||33.923|||||||||15.1073|||0||0.1313||9.605|||||||87.2162|18.3363||-2.4|35.0298||420.3575|||-1.2974||||-119.549|||||4.157|-43.178|-43.178|-4.475|13.58|13.58|586.8887|64641.9667||14.6373|12.75
adr_usa_0504|MITO|201906|54.608|53.2||0.437||36.01|25.684|10.326||19.285|||||||||12.9078|||0||0.011||8.97|||||||87.0545|35.0333||-0.48||||||-0.48||||-108.242|||||6.064|-15.75|-15.75|-0.32|12.17|12.17|372.5057|6515.8||12.515|8.9
adr_usa_0504|MITO|201909|38.918|37.23||0.421||35.894|27.795|8.099||3.695|||||||||56.6923|||0||0.0268||7.284|||||||87.6329|35.0333||-0.48|36.392||420.3998|||-0.48|-78.226|||-102.047|||||6.269|-16.53|-16.53|-0.441|5.22|5.22|146.4186|16142.9||6.32|11.6071
adr_usa_0504|MITO|201912|52.398|50.768||0.345||35.476|33.95|1.526||17.267|-497.997|||||1.5948|||6.8711||0.9406|0||0.1385||9.52|0.131||||2.7962||83.7638|36.3146|31|0.24|36.3934||436.7208||1.4954|0.24||||-71.728|||21.087||5.825|3.73|3.73|-0.442|3.45|3.45|105.1664|214999.1333|-84.5833|2.52|1.85
adr_usa_0504|MITO|202003|31.862|31.242||0.285||29.72|29.72|0||2.427||||||0.5407|||18.5941|||0||0.0777||6.513||||1|2.364||87.4364|36.3934||-0.48|36.3934||436.7208|||-0.48||||-44.09|||||5.18|-15.54|-15.54|-0.513|1.29|1.29|16.0608|1192063.2|-90.3125|1.69|2.1201
adr_usa_0504|MITO|202006|32.916|31.834||0.224||22.09|22.09|0||11.585|||||-0.3664|1.3115|||7.8201|||0||0.0094||5.003||||1|2.9093||1.6666|47.9492||-0.24|49.5061||594.0735|||-0.24|-20|||-40.709|||||4.523|-12.369|-12.369|-0.441|1.83|1.83|75.8187|136738.6333|-85.36|2.12|1.51
adr_usa_0504|MITO|202009|21.652|19.893||0.169||20.251|20.251|||2.274|-537.116||||-0.3117|1.0703|||29.6217|||0||0.1962||3.452|0.179|||1|2.4176||1.6641|49.7417||-0.24|49.8961||598.7535|||-0.24|-20.673|||-35.389|||||4.671|-11.21|-11.21|-0.328|1.35|1.35|56.4487|85941|-77.4247|1.5162|1.32
adr_usa_0504|MITO|202012|35.04|32.787||0.106||46.22|21.049|25.171||-10.372|-555.454||||-0.3055|1.0491|||33.3518|||||0.0868||3.526|0.191|||1|2.0855||2.0353|51.2502|29|-0.36|52.9243||635.0921|||-0.2211||||-57.457|||||4.992|-18.338|-18.338|-0.387|1.57|1.57|64.9311|763220.2333|-54.1411|1.74|1.81
adr_usa_0504|MITO|202103|33.987|32.06||0.092||46.86|16.206|30.654||-12.079|||||-0.345|1.1849||||||||0.1911||4.62||||2|1.5398||6.32|54.4006||-0.12|||667.3997|||-0.1878||||-49.606|||||4.979|-7.689|-7.689|-0.299|1.47|1.47|62.4941|348905.5333|26.6129|1.25|1.31
adr_usa_0504|MITO|202106|31.61|30.766||0.072||58.573|13.415|45.158||-26.315|-581.549||||-0.4204|1.2232||||||||0.5616||2.566|0.207|||1|-0.0591||2.6797|56.2382||-0.36|57.5828||690.9938|||-0.2316|-6.903|||-55.643|||||5.083|-18.406|-18.406|-0.187|1.5|1.5|64.5152|3827152.7667|-14.7541|1.35|1.34
adr_usa_0504|MITO|202109|43.44|42.277||0.115||73.019|9.658|63.361||-28.832|||||-0.323|0.94||||||||1.9235||3.915||||2|-0.1564||1.6289|57.7094||-0.12|57.5828||690.9938|||-0.2126||||-50.73|||||4.707|-6.297|-6.297|-0.196|1.36|1.36|52.4228|481229.4|0.7407|1.15|0.85
adr_usa_0504|MITO|202112|||||||||||||||-0.1242|||||||||0.1041||||||2|-1.2491||1.6268||||||||||||||||||||||0.7825|0.7825|16.1796|117608.9|-44.4816|0.62|0.62